A pharmaceutical executive collapsed in the Oval Office Thursday as members of the Trump administration were announcing a new deal for weight-loss medications.
The person, believed to be Novo Nordisk executive Gordon Findlay, was standing behind the president during the event when, suddenly, his knees buckled from underneath him, according to a report by The Independent.
🚨HOLY SHIT: Gordon Findlay, part of the Novo Nordisk team, just collapsed in the Oval Office, standing behind Trump as his administration's health officials were announcing Ozempic's lower pricing. The press conference was called off immediately as the medical crew rushed in. pic.twitter.com/0dXbb732xT— CALL TO ACTIVISM (@CalltoActivism) November 6, 2025
The incident took place when Eli Lilly CEO Dave Ricks was making his remarks.
Reporters who witnessed the incident first-hand said Dr Mehmet Oz, the Administrator for Centers for Medicare & Medicaid Services, helped the executive to the ground, preventing him from hitting his head. As reporters were ushered out of the Oval Office, cabinet members attended to the man, elevating his legs.
White House Press Secretary Karoline Leavitt later said in a statement, “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.